

In a joint letter, MSF and several concerned groups and individuals addressed Dr. Anthony Fauci, the head of the US National Institute of Allergy and Infectious Diseases (NIAID), asking that NIAID not grant exclusive rights in a HIV patent license for South Africa, India and other low-income countries. The letter asks that exclusivity not extend to these low- and middle-income countries regarding a license issued to the company RNAceuticals for a US federally funded HIV treatment.